News|Articles|October 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-10-02-2004
  • Volume 28
  • Issue 10

Drug Development Linked More Closely to Diagnostics

Author(s)Jill Wechsler

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.
External Link - article-128386.pdf

Articles in this issue

over 21 years ago

A Novel Freeze Pelletization Technique for Preparing Matix Pellets

over 21 years ago

Aseptic Processing: A Review of Current Industry Practice

over 21 years ago

Can Inserts Be Improved?

over 21 years ago

Analysis of a Kneading Process to Evaluate Drug Substance-Cyclodextrin Complexation

over 21 years ago

Preparation and In Vitro Characterization of Self-Nanoemulsified Drug Delivery Systems of Coenzyme Q10 Using Chiral Essential Oil Components

over 21 years ago

In The Spotlight-October 2004

over 21 years ago

October 2004

over 21 years ago

Visible-Residue Limit for Cleaning Validation and its Potential Application in Pharmaceutical Research Facility

over 21 years ago

The High Price of Success

over 21 years ago

Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content